切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2015, Vol. 04 ›› Issue (03) : 250 -253. doi: 10.3877/cma.j.issn.2095-3224.2015.03.06

所属专题: 文献

青年专家论坛

BMI指数与大肠癌发生机制的相关性研究
陈瑛罡1()   
  1. 1. 150086 哈尔滨医科大学附属第二医院结直肠肿瘤外科 哈尔滨医科大学大肠癌研究所
  • 收稿日期:2015-04-27 出版日期:2015-06-25
  • 通信作者: 陈瑛罡

The study of the correlation between body mass index and colorectal cancer mechanism

Ying-gang CHEN1,()   

  1. 1. Department of Colorectal Surgery, Second Affiliated Hospital of Harbin Medical University.Colorectal Cancer Institute of Harbin Medical University, Harbin 150086, China
  • Received:2015-04-27 Published:2015-06-25
  • Corresponding author: Ying-gang CHEN
  • About author:
    Corresponding author: CHEN Ying-gang, Email:
引用本文:

陈瑛罡. BMI指数与大肠癌发生机制的相关性研究[J/OL]. 中华结直肠疾病电子杂志, 2015, 04(03): 250-253.

Ying-gang CHEN. The study of the correlation between body mass index and colorectal cancer mechanism[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2015, 04(03): 250-253.

超重或肥胖是一种病理状态,近年研究认为肥胖是包括结直肠癌在内的多种肿瘤的危险因素之一。目前研究发现脂肪组织分泌的一些因子与结直肠肿瘤发生、发展相关。本文针对肥胖的病理生理状态以及相关因子与结直肠肿瘤发生的分子机制作一综述。

Overweight or obesity is a pathologic status.Recently, obesity is known as one of the risk factors of several kinds of tumors including colorectal cancer.Some studies showed that fat tissue could secrete some factors relevant to the development and progress of colorectal cancer.This review article introduced the pathophysiological status of obesity and the correlation between relevant factors and the molecular mechanism of colorectal cancer.

[1]
李立明,饶克勤,孔灵芝,等.中国居民2002年营养与健康状况调查.中华流行病学杂志,2005,26(7): 478-484.
[2]
Zheng S, Cai SR.Colorectal cancer epidemiology andprevention study in China.The Chinese-German Journal of Clinical Oncology, 2003, 2(2): 72-76.
[3]
Pischon T, Lahmann PH, Boeing H, et al.Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition(EPIC). J Natl Cancer Inst, 2006, 98(13): 920-931.
[4]
Sedjo RL, Byers T, Levin TR, et al.Change in body size and the risk of colorectal adenomas.Cancer Epidemiol Biomarkers Prev, 2007, 16(3): 526-531.
[5]
Cowey SL, Quast M, Belalcazar LM, et al.Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.Cancer, 2005, 103(12): 2643-2653.
[6]
Watkins LF, Lewis LR, Levine AE.Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line.Int J Cancer, 1990, 45(2): 372-375.
[7]
Guo YS, Narayan S, Yallampalli C, et al.Characterization of insulinlike growth factor Ⅰ receptors in human colon cancer.Gastroenterology, 1992, 102(4Pt 1): 1101-1108.
[8]
Esposito K, Nappo F, Marfella R, et al.Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.Circulation, 2002, 106(16): 2067-2072.
[9]
Eaden JA, Abrams KR, Mayberry JF.The risk of colorectal cancer in ulcerative colitis: a meta-analysis.Gut, 2001, 48(4): 526-535.
[10]
Yan SR, Joseph RR, Rosen K, et al.Activation of NFkappaB following detachment delays apoptosis in intestinal epithelial cells.Oncogene, 2005, 24(43): 6482-6491.
[11]
Chapkin RS, Davidson LA, Ly L, et al.Immunomodulatory effects of(n-3)fatty acids: putative link to inflammation and colon cancer.J Nutr, 2007, 137(1 Suppl): 200-204.
[12]
Zhang Y, Proenca R, Maffei M, et al.Positional cloning of the mouse obese gene and its human homologue.Nature, 1994, 372(6505): 425-432.
[13]
Isse N, Ogawa Y, Tamura N, et al.Structural organization and chromosomal assignment of the human obese gene.J Biol Chem, 1995, 270(46): 27728-27733.
[14]
Stattin P, Lukanova A, Biessy C, et alObesity and colon cancer: does leptin provide a link? .Int J Cancer, 2004, 109(1): 149-152.
[15]
Hardwick JC, Van Den Brink GR, Offerhaus GJ, et al.Leptin is a growth factor for colonic epithelial cells.Gastroenterology, 2001, 121(1): 79-90.
[16]
Rouet-Benzineb P, Aparicio T, Guilmeau S, et al.Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling.J Biol Chem, 2004, 279(16): 16495-16502.
[17]
Attoub S, Noe V, Pirola L, et al.Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways.FASEB J, 2000, 14(14): 2329-2338.
[18]
Hoda MR, Keely SJ, Bertelsen LS, et al.Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells.Br J Surg, 2007, 94(3): 346-354.
[19]
Garofalo C, Surmacz E. Leptin and cancer.J Cell Physiol, 2006, 207(1): 12-22.
[20]
Culig Z, Steiner H, Bartsch G, et al.Interleukin-6 regulation of prostate cancer cell growth.J Cell Biochem, 2005, 95(3): 97-505.
[21]
Fenton JI, Hursting SD, Perkins SN, et al.Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc(Min/+)colon epithelial cell line.Carcinogenesis, 2006, 27(7): 1507-1515.
[22]
Koji H, Saki I, Kojiro M. NF-κB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor-α.Biol Pharm Bull, 2006, 29(12): 2372-2377.
[23]
Zins K, Abraham D, Sioud M, et al.Colon cancer cellderived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by upregulating the colony-stimulating factor-1 pathway.Cancer Res, 2007, 67(3): 1038-1045.
[24]
Petak I, Danam RP, Tillman DM, et al.Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.Cell Death Differ, 2003, 10(2): 211-217.
[25]
Wolf I, Sadetzki S, Kanety H, et al.Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.Cancer, 2006, 106(4): 966-973.
[26]
Dignam JJ, Polite BN, Yothers G, et al.Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.J Natl Cancer Inst, 2006, 98(22): 1647-1654.
[27]
Haydon AM, Macinnis RJ, English DR, et al.Effect of physical activity and body size on survival after diagnosis with colorectal cancer.Gut, 2006, 55(1)62-67.
[1] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[2] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[3] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[4] 谢丽春, 欧庆芬, 张秋萍, 叶升. 简化和标准肝脏MRI方案在结直肠癌肝转移患者随访中的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 434-437.
[5] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[6] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[12] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[13] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[14] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[15] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
阅读次数
全文


摘要